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RESEARCH ARTICLE Open Access
Family tree and ancestry inference: is there
a need for a ‘generational’ consent?
Susan E. Wallace1* , Elli G. Gourna1, Viktoriya Nikolova1 and Nuala A. Sheehan1,2
Abstract
Background: Genealogical research and ancestry testing are popular recreational activities but little is known about
the impact of the use of these services on clients’ biological and social families. Ancestry databases are being
enriched with self-reported data and data from deoxyribonucleic acid (DNA) analyses, but also are being linked to
other direct-to-consumer genetic testing and research databases. As both family history data and DNA can provide
information on more than just the individual, we asked whether companies, as a part of the consent process, were
informing clients, and through them clients’ relatives, of the potential implications of the use and linkage of their
personal data.
Methods: We used content analysis to analyse publically-available consent and informational materials provided to
potential clients of ancestry and direct-to-consumer genetic testing companies to determine what consent is
required, what risks associated with participation were highlighted, and whether the consent or notification of third
parties was suggested or required.
Results: We identified four categories of companies providing: 1) services based only on self-reported data, such as
personal or family history; 2) services based only on DNA provided by the client; 3) services using both; and 4)
services using both that also have a research component. The amount of information provided on the potential
issues varied significantly across the categories of companies. ‘Traditional’ ancestry companies showed the greatest
awareness of the implications for family members, while companies only asking for DNA focused solely on the
client. While in some cases companies included text recommending clients inform their relatives, showing they
recognised the issues, often it was located within lengthy terms and conditions or privacy statements that may not
be read by potential clients.
Conclusions: We recommend that companies should make it clearer that clients should inform third parties about
their plans to participate, that third parties’ data will be provided to companies, and that that data will be linked to
other databases, thus raising privacy and issues on use of data. We also suggest investigating whether a
‘generational consent’ should be created that would include more than just the individual in decisions about
participating in genetic investigations.
Background
Genealogical research, or the tracing of ethnic origin
and ancestry, although a well-established process for sci-
entific and demographic research, has also become in-
creasingly popular as a recreational activity in recent
years. Traditionally, public records including birth and
marriage certificates, census statements, interviews and
immigration data were the main sources of information
for making ancestral links. Companies have been created
to assist individuals to ascertain their genetic heritage
and fill out family trees, or pedigrees. More recently,
technological advances and significantly lower analysis
costs have resulted in a number of companies incorpor-
ating deoxyribonucleic acid (DNA) analysis further enab-
ling people to seek out relatives. Moreover, direct-to-
consumer (DTC) genetic testing services now include
ancestry information as one of the benefits of joining.
This merging of genealogical research with genetic test-
ing is becoming more commonplace [1]. Genealogical
data are routinely being added to biobanks to enrich the
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resource. Despite the fact that genetic association studies
are typically carried out on unrelated individuals, pedi-
grees have recently been recommended as an ideal de-
sign for finding rare genes, for controlling for population
stratification effects and for deep sequencing of affected
family members [2–4]. In the light of recent methodo-
logical developments, pedigrees can now be actively
sought in large datasets of supposedly unrelated individ-
uals and can, in principle, be reconstructed from anon-
ymised population cohort study genetic marker data [5–9].
Genealogical research, both for scientific and recreational
purposes, is joining the ‘big data’ revolution.
Yet the impact on relatives of a decision by one indi-
vidual to obtain, and perhaps share, genetic information
has not been fully explored. Much literature has been
written on best practices in sharing genetic and ancestry
knowledge within certain specialties such as clinical gen-
etics and genetic counselling [10, 11]. Revealing misat-
tributed paternity has long been a concern in sharing
pedigree information, but additional issues are raised by
ancestry testing. The American Society of Human Gen-
etics in their 2008 statement on ancestry testing, notes
that it is an inexact science and assumptions can be
made based on subjective data, for example, “…imply
[ing] clear-cut connections between DNA and specific
regions and ethnic groups…”[12]. If the connection is
not welcome or at odds with existing beliefs, such impli-
cations can cause distress or disbelief. The ASHG notes
that, “[t]he occurrence of or potential for emotional dis-
tress in people or groups following receipt of conflicting
information about their ancestry has been documented,
but still needs more research [12].
The rise in popularity of recreational genomics, seen
through television programmes and company advertise-
ments, shows that people are eager to seek out and share
their ancestry data. But, genetic information implicates
not only the individual but their biological relatives and
social family, and third parties to ancestry investigations
have received limited consideration. A 2015 statement
from the Genetic Genealogy Committee, an independent
group of genealogists clearly recognises the implications
for third parties but makes no recommendation for en-
suring such parties are informed of the intent to partici-
pate in one of these companies [13]. The ease with
which genealogical and other personal data from the cli-
ent, and by extension from their relatives, can be shared,
linked and used, raises issues of who gives consent to
provide that data and how well all parties are aware of
the implications of participation.
Informed consent is an individualistic process de-
signed to allow a capable individual, with sufficient in-
formation and time, to make a decision regarding
participation. One could theorise that because genetic
information implicates others beyond the individual, the
information on which the consent is based should in-
clude details regarding the potential implications of par-
ticipation on families and relatives. Hudson et al. and
the ASHG have recommended that, “Companies offering
DTC testing should clearly disclose all risks associated
with testing, including psychological risks and risks to
family members” [14]. Using our knowledge of best
practice in the creation of consent forms, through previ-
ous work including creating consent templates [15], we
examined privacy and data management procedures
used by companies offering ancestry testing and estima-
tion to determine whether the needs and wishes of fam-
ily members (biological relatives, in particular) are taken
into account when an individual chooses to use these
companies’ services and when (s)he opts to share the
findings from the performed analyses with other users
on online databases.
Methods
We first conducted a preliminary search using the data-
bases PubMed, Scopus and Web of Knowledge looking
for papers discussing recreational and genetic ancestry.
At the same time we searched using the search engine
Google for companies providing recreational genealogy
services, (genetic) ancestry testing and conducting re-
lated research. We used the following key words (and
combinations of keywords) to focus our search specific-
ally in the area of genealogy and ancestry testing: geneal-
ogy, genealogy service, recreational genealogy, genetic
genealogy, family history, family tree, ancestry, combined
with the words company OR service OR organisation
OR provide OR business. We excluded key words such
as DNA testing as they moved the search into the do-
main of clinical testing which was outside the focus of
this paper.
The search revealed numerous companies offering a
wide range of genealogy and genetic services and several
types of ancestry tests. To limit our results we used the
following inclusion criteria: a) web-page in English; b)
providing commercial services; c) located in the United
Kingdom or United States; and d) a primary focus on
recreational ancestry using data and/or DNA samples
provided by an individual (hereafter ‘client’). We ex-
cluded companies or laboratories that primarily offer a
specific type of test other than ancestry (e.g. paternity
test, immigration or forensic test) and websites that only
promote such services. Because many companies had
multiple locations and provided services online, we
abandoned the location criteria. To ensure that no com-
panies previously studied were overlooked, the list of gen-
etic genealogy companies produced by Royal et al. [16]
was also reviewed. Twenty-one companies, including sub-
sidiary companies, fulfilled our criteria and were included
in the analysis (Table 1).
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We conducted a directed content analysis [17] to valid-
ate our theory that for consent to be informed, individuals
should be notified of the potential implications of partici-
pation on their family and relatives. We collected publi-
cally available consent policies, privacy policies and terms
of conditions (hereafter T&C, or terms of use) documents
and highlighted what information is given to the potential
client, what consent is required, what risks associated with
testing were mentioned, and whether obtaining the con-
sent of or the need to notify third parties was mentioned.
Homepages; “About us” pages; and Frequently Asked
Questions (hereafter FAQ) pages were also searched. All
documents were imported and coded using NVivo 10 to
facilitate the analysis. Initial codes were generated from
the research questions that guided but did not constrain
the analysis. Codes were developed and iteratively revised.
They included (but were not limited to) consent for the
individual, alternative forms of agreement, consent for
third parties, proof of consent and family considerations.
In the first stage of the analysis, companies were placed in
categories based on the services provided. Next, detailed
charts were produced that included coded sections of text
for each group. Similarities and differences in text were
compared; we also highlighted where text was included or
when it was missing. Based on these tables we were able
to judge whether there was overt discussion of the impli-
cations for others as a result of consenting to participate.
Results
We identified four categories of companies offering rec-
reational genealogy services (Table 1): 1) companies that
provide genealogy services based only on self-reported
data, such as personal or family history; 2) companies
that provide genealogy services based primarily on a DNA
sample provided by the client; 3) companies that provide
genealogy services using both self-reported data and that
from the DNA sample; and 4) companies that also have a
research component.
Group 1: companies that provide ancestry services based
on self-reported data
Ten companies were included in the first group: Ancestry,
AncestryHealth, Archives, FamilyLink, Family Search,
Find My Past, Genes Reunited, Geni, MyHeritage, The
Genealogist, and World Vital Records. These companies
provide what might be called ‘traditional’ family history
services. They help users discover their distant relatives
through access to census records, marriage and death
records, military records, etc. Clients provide personal in-
formation (name, gender, year of birth, address etc.); per-
sonal information for other people (e.g. names and
birthdays of family members); and dates and places of
events (e.g. birth, death, marriage, divorce, immigration,
etc.). Clients may keep their family histories private if they
wish. Alternatively, they may choose to make their histor-
ies openly available enabling other service users to search
these histories for common relatives. AncestryHealth,
which focuses on health history, suggests clients may wish
Table 1 Characteristics of companies included in the analysis
Companies Ancestry
services
based on
self-reported
data
Ancestry
services
based on
a DNA
sample
Ancestry
services
based on
self-reported
data and a
DNA sample
Offers a
Research
Component
in addition to
other services
23andMe
(23andMe
Research)
√ √
African Ancestry √
African DNA √
Ancestry by
DNA
√
Ancestrya √
AncestryDNAa
(Ancestry
Human Diversity
Project)
√ √
AncestryHealtha
(Ancestry
Human Diversity
Project)
√
Archivesb √ √
Archivesb √
DNA Testing
Systems
√
DNA Tribes √
Family Search √
Family Tree
DNA (various
projects)
√
FamilyLinkb,c √
Find My Past √
Genes Reunited √
Genib √
MyHeritageb,c √
Oxford
Ancestors
√
Roots for Real √
The
Genealogistb
√
World Vital
Recordsb,c
√
aAncestryDNA and AncestryHealth are subsidiaries of Ancestry
bThese companies outsource DNA testing to other companies (FamilyLink,
GENI and The Genealogist, World Vital Records use FTDNA; Archives use
Ancestry; and MyHeritage uses FTDNA or 23andMe)
cFamilyLink, GENI and World Vital Records are subsidiaries of MyHeritage
Wallace et al. BMC Medical Ethics  (2015) 16:87 Page 3 of 9
to share their AncestryHealth records with their physi-
cians [18].
All but one of the companies (The Genealogist) men-
tion in their Privacy Policy or T&C document that con-
sent is implied by the use of the website or the purchase
of their products. For example, “By accepting these
Terms and registering as a member of the Genes
Reunited Service, you give your consent for your per-
sonal data to be stored and processed in accordance
with our Privacy Policy” [19]. The majority of the com-
panies (eight of ten) also recognise that potential com-
plications may arise from providing and sharing
genealogical information that relates to individuals other
than the client. This is evidenced by the frequent pres-
ence of statements emphasising that it is the responsibil-
ity of the client to obtain consent from living family
members prior to sharing information about them on
the website and to make the implications of that consent
clear. Moreover, some companies also insist that their
clients should obtain the consent of third parties and be
able to provide the company with the necessary docu-
mentation, if requested (Table 2).
As noted by FindmyPast, controls are included to
allow clients to decide which pieces of information can
be shared openly.
On some parts of the website, you can publish things
(including your family tree), make comments or
participate on forums. If you do, you must not:
publish something that you do not own the copyright
in (or have permission to publish it from the
copyright owner); […]; or share the personal
information of living people without their
permission. You’re responsible for managing content
you create, including using privacy settings we make
available [20].
Six of these companies (Archives, FamilyLink, Geni,
My Heritage, The Genealogist and World Vital Records)
collaborate with other companies that offer DNA tests
to enrich the ancestry information that can be inferred.
In these cases, a separate link is provided that directs
the client to the privacy policy document of the company
offering the DNA test. More specifically, MyHeritage offers
its clients the option of using either 23andMe or Family-
TreeDNA for the DNA test. FamilyLink, Geni, The Ge-
nealogist and World Vital Records uses FamilyTreeDNA,
while Archives collaborates with AncestryDNA. These are
discussed below (Group 3).
Group 2: companies that provide ancestry services based
on a DNA sample
Seven companies (African Ancestry, African DNA,
Ancestry by DNA, DNA Testing Systems, DNA Tribes,
Oxford Ancestors and Roots for Real) provide ancestry
services based mainly on the analysis of a DNA sample
provided by the client. These offer information about
the individual’s ancestral origins, such as the percentage
of their ancestors who were of African, European and
Native American ancestry. Three of the companies
(AfricanAncestry, DNAConsultants and OxfordAncestors)
have a “consent by use” statement. For example, Oxford
Ancestors states that, “By placing an order you signify that
you freely and specifically consent to the collection and
processing of any personal data you provide” [21]. African
Ancestry asks clients to confirm that they have the right
to submit samples from others: “By submitting a sample
for analysis, the Customer warrants that it has the right to
take and submit the sample and that it does so either as
owner of all samples involved or with full authority of the
owner of all such samples” [22]. Concerns over ownership
of samples as cited by these companies could be inter-
preted to reflect the fact that in some countries, such as
the UK, legislation is in place to protect against the collec-
tion and use of DNA samples without the explicit consent
of the person from whom it was taken [23]. The
remaining four companies do not have a consent by use
statement and no specific mention is made by any of the
companies about the ethical implications for third parties,
such as possible adverse psychological reactions to genetic
ancestry data [12].
Group 3: companies offering ancestry services based on
self-reported data and a DNA sample
Three companies (23andMe, AncestryDNA and Family
Tree DNA) collect a wide range of information (name;
address; health-related information; personal traits; and
family history) and DNA samples. They use them to
provide information about one’s deep ancestral origin as
well as a list of potential genetic matches (potential rela-
tives) from the company’s ever expanding database. In
addition, 23andMe, through only their United Kingdom,
Canadian and European branches, also offer health-
related information and specifically, using variants or
markers, information about genetic risk factors, inher-
ited conditions, pharmacogenetics and other traits (e.g.
earwax type). 23andMe was suspended from providing
health-related data to their clients in the United States
in 2013; however, they are taking steps to return to their
previous position by recently receiving marketing ap-
proval from the US Food and Drug Administration for a
carrier test for Bloom Syndrome [24].
As previously mentioned, these companies provide
services to clients referred through other ancestry com-
panies. These companies may also outsource the actual
DNA analyses to specific (usually Clinical Laboratory
Improvement Amendments (CLIA) certified) laborator-
ies. 23andMe uses LabCorp for the genotyping services
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while Family Tree DNA uses the Genomics Research
Center run by GenebyGene. As with other companies
discussed, consent is deemed to be given when services
are purchased. “By using the AncestryDNA Website and
the Services you consent to the collection, use, storage
and disclosure of your Personal Information by Ances-
tryDNA in accordance with this Privacy Statement” [25].
These companies however are more specific when de-
tailing the services to which one is consenting. 23andMe,
for example, is very explicit about the circumstances
under which the information provided is going to be
used.
By agreeing to our Privacy Statement and Terms of
Service, you consent to sensitive information, such as
information about your health, Genetic Information,
and Self-Reported Information such as racial and ethnic
origin and sexual orientation (where you provide it)
being used by us to: analyze and provide you with our
Services; analyze and provide you with information
about your ancestry; determine whether you would be
suitable to take part in surveys, polls or questionnaires
that we are conducting; and monitor and improve
existing products or services that we offer or develop
new products and service [26].
Furthermore, 23andMe and AncestryDNA demonstrate
concern for third parties by asking their clients to obtain
consent from other people before using their information.
AncestryDNA states that,
You should obtain the consent from the living
persons about which you want to post personal
information on the Websites, or, if the person is
under the age of 18, the consent of their parent or
guardian [27].
23andMe cautions, “Where you are disclosing infor-
mation about a family member, you should make sure
that you have permission from the family member to
do so”[24]. Interestingly, 23andMe recently added a
new page to its website specifically focusing on “Family
Considerations”.
Looking at your genetic data might uncover
information that some people find surprising. This
information can be relatively benign and even
amusing. At other times, the information you learn
can have profound implications for both you and your
family [28].
In that document they cover issues relating to families
(revealing information about new biological relatives or
misattributed paternity); ancestry; health (increased risk
of a particular condition) and relationships. They spe-
cifically mention:
Because genetic information is hereditary, knowing
something about your genetics also tells you
something about those closely related to you. Your
family may or may not want to know this
Table 2 Quotes from company privacy policy or T&C documents referring to the need to obtain consent from family members
Company Quote from privacy policy/T&C document
Ancestry You should obtain the consent from the living persons about whom you want to post personal information on the Websites, or, if
the person is under the age of 18, the consent of their parent or guardian [48].
AncestryHealth Before providing health and lifestyle information about others, you represent that you have obtained the consent from them, or, if
the person is under the age of 18, the consent of their parent or guardian [49].
Archives […][Y]ou should only submit or share User Provided Content that belongs to you (or where you have obtained all necessary
permissions or consents) and that will not violate the rights of others [50].
Family Search When providing personal information about anyone other than yourself, you must first obtain the other person’s informed consent
if his or her consent is legally required [according to local law] [51].
FindMyPast You should always seek permission from people who are living before you make their personal information available in your tree, or
anywhere else online. […] We reserve the right (at our own discretion) to remove any personal data which you have included in
your family tree about people who are living if we are alerted to the fact that this personal data was used without that person’s
permission [52].
GenesReunited You promise that you are the original owner of any Submission you make or you have the necessary licences, rights, consents, and
permissions to authorise us to use your Submission. In particular, you promise that you have obtained the permission of all of the
living people featured or referred to in the Submission (and if they are under 18 their parents’ or guardians’ permission as well).[…]
You agree to give us evidence of all such licences, rights, consents, and permissions if so requested by us [19].
Geni [I]s prohibited to […] posting any third party’s (including without limitation any family member’s) information on the Geni Services
without permission [53].
MyHeritage In addition you should also make sure that information or material you wish to place on the Website about anyone living is only
posted with their prior knowledge and consent. If the person is under the legal age to enter into agreements (typically 18 years
old), you represent that you have obtained the consent of the parent or guardian of the person under the legal age […]. In all
cases, you must make the implications of the consent clear to the person (or, if applicable, to the parent/guardian) [54].
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information as well, and relationships with others
can be affected by learning about your DNA.
Everyone has different tolerances and preferences
for learning information. You might be surprised by
a family member who would prefer not to know
something you feel is important to share. At other
times, you may learn something about yourself, your
family, your ancestry, or health-related associations
with your genotype that you would prefer to keep
private. You may find yourself having to weigh
sharing such information with other family members
against your own desire for privacy - or their desire
not to know [28].
Group 4: companies that also offer a research component
The companies in category 4 (23andMe, AncestryDNA,
AncestryHealth, and FamilyTreeDNA) have an open re-
search component where clients can give consent for the
use of the genealogical data and DNA samples to be
used for a variety of research purposes. These studies
range from more traditional genealogical research with
non-profit groups [29] to biomedical research using gen-
etic data.
Family Tree DNA offers the opportunity to participate
in a variety of volunteer-lead projects and to combine
personal DNA data with that from others to explore, for
example, the history of particular surnames or geograph-
ical locations. Clients are informed about the necessary
broad and explicit consent required depending on the
circumstances. General consent is needed to participate
in any GenebyGene services, while explicit consent will
be asked for participating in specific research activities,
which may involve allowing access to the anonymised
data or to their personal, non-anonymised data, depend-
ing on the study. Their research partners may include,
“…commercial or non-profit organizations that conduct
or support population genetic studies, scientific/medical
research, or the development of drugs or devices to diag-
nose, predict, or treat health conditions” [30].
The Ancestry Human Diversity Project is run by An-
cestry and can be joined through either AncestryDNA
or AncestryHealth. This project also seeks, “to better
understand, among other things, human evolution and
migration, population genetics, population health issues,
ethnographic diversity and boundaries, genealogy, and
the history of our species” [31]. Both companies provide
publically available consent forms [32, 33] describing the
information that might be required (e.g. genealogical
and genetic information) and ask potential clients to sign
it in addition to accepting the T&C of the company.
Although a wide range of information is requested, in-
cluding pedigree and family history data, no specific
concerns are expressed regarding third party interests:
they only acknowledge that test results might reveal
information about others. For example, AncestryDNA
states the following:
Your test results may reveal information about you or
your biological family (blood relatives), but there are
no physical risks for providing a saliva sample and
having your sample and Information used in this
Project [32].
At this time there is no formal link between Ances-
tryDNA and AncestryHealth. However, industry observers
believe that it is only a matter of time before these two
subsidiaries link their family history, self-reported and
DNA data to enable Ancestry.com to provide health-
related information to clients [34], in a similar way to
23andMe as described above.
23andMe Research shows the company’s decision to
move decisively into biomedical research. It works with
patient communities, academic researchers and pharma-
ceutical companies, and publishes its results in peer-
reviewed journals. All research activities are overseen by
an independent institutional review board. Due to its
large client population and access to associated data, it
claims to be able to produce useful research results in a
shorter time than other more traditional biomedical re-
search projects [35]. Their research consent states that
genetic and self-reported information will be collected
including information submitted prior to giving consent
[36]. With regard to the possible risks associated with
such consent, their research consent document only
mentions that, “[s]ome survey questions may make you
or your family members uncomfortable” [36]. While this
acknowledges that the use of this information might
affect family members, it does not require family mem-
bers to consent, and it does not mention that family
members should be informed about the client’s intention
to join a research project. The Family Considerations
page, provided by 23andMe, is not repeated for
23andMe Research.
Discussion
Our analysis showed that the amount of text discussing
the need to take third parties into consideration,
whether biologically related or not, varied substantially
across the activities we examined. Companies solely of-
fering more ‘traditional’ ancestry services, without DNA
analyses, more clearly highlight the issues. They acknow-
ledge that ancestry information is shared across families
and that their consent should be sought. However, when
DNA analysis is included or is the sole means of partici-
pation, there is a shift to language focusing on the pro-
tection of the use of personal or sensitive information of
the client and ownership of DNA samples, with little
language about third parties. Once activities move from
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‘recreational’ to ‘research,’ such as with the four compan-
ies offering a research component to clients, the lan-
guage reflects existing regulations and norms, such as
the need for independent ethics oversight, but not impli-
cations for third parties. With the exception of
23andMe’s Family Considerations text, little focus is
placed on the implications for the use and spread of data
beyond the individual.
These differences appear to indicate that family history
data and DNA are thought of in different ways. Attitudes
towards family history data reflect its name – people
recognise it as involving more than just the individual.
Attitudes towards the brokering of DNA, on the other
hand, can be seen in two different ways. Family consid-
erations may not be discussed because of a lack of un-
derstanding of its familial nature. Or, it may be because
companies have chosen a goods-for-service paradigm
which is commonly used in business and protected
through the law. This confirms our finding that compan-
ies see the client as the single decision-maker on
whether their information and any family history, pedi-
gree or personal data of others with whom they are re-
lated or associated should be shared on the company’s
database or across companies. This is not surprising as
their ‘contract’ is with the purchaser of their services.
They may highlight the issue, such as with 23andMe,
but again only with the client. Any language is mainly
placed in privacy policies or terms of use agreements,
documents that may not be readily obvious, or even of
interest, to the client. Such a model places the onus of
knowing the implications and communicating those to
the client.
Allowing clients to self-regulate their family’s privacy
may no longer be sufficient. The level of understanding
that clients possess regarding genealogy information is
questionable [37, 38] and it is not known how many ac-
tually read the terms and conditions or privacy state-
ments provided. Moreover, while it is obvious to most
people that dates and records of family members might
not be personal data and could affect others, it is not
clear that a saliva sample is viewed the same way. Much
has been written about fallibility of anonymisation.
Given expertise, resources and will, it is possible to re-
identify individuals from anonymised family history data
[39] suggesting that procedures such as name removal
and encoding are not sufficient to protect against privacy
breaches. Another concern is whether clients or third
parties actually know that their data may move to juris-
dictions with differing data protection regimes. Linkage
is another potential concern. Family Tree DNA offers to
their clients the possibility to transfer in their raw data
from the databases 23andMe or AncestryDNA to find
new possible matches in their database. AncestryDNA
and AncestryHealth are expected to link their extensive
datasets. Genealogical databases are contributing to sci-
entific research, such as through Familinx which com-
bines and links pedigrees contributed by My Heritage
clients and others for scientific research [40]. But they
have also been used to show that, together with other
public on-line resources, “…full identities of personal
genomes can be exposed via surname inference” [41].
Do relatives understand the possibilities? Is one person’s
consent enough or is something more needed?
Conclusions
Traditional informed consent reflects individualistic
decision-making. We argue that it is time to think of
consent in broader terms, as a discussion that, when in-
volving genetic information, goes beyond the individual
and asks all parties to think about and involve the
broader family and biological relatives. In the context
of this study, we suggest companies notify potential cli-
ents of the implications for third parties and ask them
to inform those third parties of plans to participate.
While it would continue to be the responsibility of the
client to decide who should be notified, we suggest
companies should not ignore the possible ramifications
for their clients. At a minimum this could be additional
text clearly displayed in a location where it will be seen
and written in accessible language, and a line on the
consent form that when ticked indicates agreement.
We recognise that ensuring clients are aware of this in-
formation is difficult, and we invite further discussions
with the companies studied to determine how such
provisions might be put into place and successfully
followed.
We also suggest that these broader discussions could
be seen as the basis for creating a ‘generational consent’
model. For this we can take the lead from those involved
in traditional forms of family association studies and
genetic counselling – begin with the individual and let
them take you to the third parties to continue the dis-
cussion. We also should take advantage of the enthusi-
asm shown by people becoming involved in ancestry,
genealogy and genetic investigations to open and expand
the dialogue. There will be instances of harm, such as
misattributed paternity, and we must continue to inves-
tigate greater protections for personal data. There will
be legal questions and debates regarding the ownership
of genetic data [42–44]. But re-identification is happen-
ing and ancestry data is moving into human subjects re-
search and being used to inform healthcare decisions.
More openness and discussion is needed around the col-
lection, linkage and use of pedigree data. If generational
consent is seen a way forward, the intricacies of such a
process will need considerable thought and discussion.
Middleton et al., in their study of the attitudes toward
the return of incidental results from sequencing
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research, note that, “…genetic health professionals and
genomic researchers agree that ancestry is not a category
of data for which it is appropriate to search for and to
share,” yet the members of the public they interviewed
showed more interest in this information [45]. More re-
search is needed to find out what the ‘generations’
around the individual think about the sharing and use of
ancestry data and the implications of learning informa-
tion that may not be wanted [46]. According to ‘Amy’, as
quoted on the GenesReunited website, “I found my sister
and mother after 1 h of logging on to this site after
53 years of not knowing where they were” [47]. But
there is no word on whether Amy’s mother and sister
were happy to be ‘found.’
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